2. PROTAC
  3. PROTAC Linkers
  4. 2955529-67-4

2955529-67-4

PI3Kα-IN-13 Chemical Structure

2955529-67-4

Chemical Structure

  • PI3Kα-IN-13
  • CAS No: 2955529-67-4
    Formula: C21H19N5O3
    Molecular Weight: 389.41
  • InChIKey: SPYYQFSRIJDCSR-KDURUIRLSA-N
  • SMILES: NC1=NC2=CC(C3=CC=C4N=CC(N5C[C@H](OCCO6)[C@H]6C5)=NC4=C3)=CC=C2O1

Biological Activity: PI3Kα-IN-13 (Compound 18a) is a PI3Kα inhibitor (IC50: 2.5 nM). PI3Kα-IN-13 induces tumor cell apoptosis. PI3Kα-IN-13 inhibits cancer cell proliferation with IC50s of 0.75 μM (MCF-7), 3.79 μM (HCT-116), 13.71 μM (MDA-MB-231), 9.85 μM (SW620), respectively. PI3Kα-IN-13 inhibits tumor cell colony formation, migration and invasion[1].

Cat. No. Product Name Purity Description
HY-156018 PI3Kα-IN-13 PI3Kα-IN-13 (Compound 18a) is a PI3Kα inhibitor (IC50: 2.5 nM). PI3Kα-IN-13 induces tumor cell apoptosis. PI3Kα-IN-13 inhibits cancer cell proliferation with IC50s of 0.75 μM (MCF-7), 3.79 μM (HCT-116), 13.71 μM (MDA-MB-231), 9.85 μM (SW620), respectively. PI3Kα-IN-13 inhibits tumor cell colony formation, migration and invasion.

References

[1]. Zheng XM, et al. Design, synthesis and bioevaluation of PI3Kα-selective inhibitors as potential colorectal cancer drugs. Eur J Med Chem. 2023 Nov 15;260:115754. [Content Brief]

Keywords:

PI3Kα-IN-13